{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:32:20Z","timestamp":1777415540206,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Technology Innovation Program of Hunan Province","award":["2017SK50901"],"award-info":[{"award-number":["2017SK50901"]}]},{"name":"Scientific Research Program of Beijing Municipal Commission of Education","award":["KM202010025020"],"award-info":[{"award-number":["KM202010025020"]}]},{"name":"Beijing Chaoyang 1351 talent training program","award":["CYXX-2017-21"],"award-info":[{"award-number":["CYXX-2017-21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Two cases with refractory macular edema secondary to adult-onset Coats\u2019 disease underwent unsatisfactory treatment by intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs and retinal photocoagulation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>The authors highlight the guiding effect of the measurement of cytokines in the aqueous humor for the treatment of adult-onset Coats\u2019 disease with refractory macular edema. In the two cases, typical Coats\u2019 disease changes, including telangiectasis, subretinal exudation and macular edema were observed. Initial treatment consisted of intravitreal anti-VEGF drugs and retinal laser photocoagulation; however, the response was poor. Then, the aqueous humor was acquired and the cytokine concentrations were measured <jats:bold>(Flow Cytometry Analysis, Beijing Giantmed Medical Diagnostics Lab<\/jats:bold>). <jats:bold>When the cytokine levels were tested every time there would be quality control, with a fixed concentration of cytokines samples to detect before the results reported.<\/jats:bold> A low level of VEGF and a high level of inflammatory cytokines were found. Then, treatment was switched to intravitreal injection of dexamethasone implant (Ozurdex\u00ae) (Allergan, Inc., Irvine, Calif., USA), which resulted in resolution of the refractory macular edema and improvement of visual acuity in both cases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>For refractory macular edema secondary to adult-onset Coats\u2019 disease, measurement of the levels of VEGF and inflammatory cytokines can help clinic doctors precisely investigate the molecular mechanism of macular edema and thereby find a suitable treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12886-020-01474-1","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T18:53:21Z","timestamp":1593543201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Levels of cytokines in the aqueous humor guided treatment of refractory macular edema in adult-onset coats\u2019 disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Yewei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1443-2667","authenticated-orcid":false,"given":"Yong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"issue":"9","key":"1474_CR1","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00417-007-0559-8","volume":"245","author":"Y Sun","year":"2007","unstructured":"Sun Y, Jain A, Moshfeghi DM. Elevated vascular endothelial growth factor levels in coats disease: rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol. 2007;245(9):1387\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"1474_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/aos.13151","volume":"95","author":"J Feng","year":"2017","unstructured":"Feng J, Zheng X, Li B, Jiang Y. Differences in aqueous concentrations of cytokines in paediatric and adult patients with Coats' disease. Acta Ophthalmol. 2017;95(6):608\u201312.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"1474_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1442-9071.1994.tb01717.x","volume":"22","author":"AP Luckie","year":"1994","unstructured":"Luckie AP, Hamilton AM. Adult Coats' disease in branch retinal vein occlusion. Aust N Z J Ophthalmol. 1994;22(3):203\u20136.","journal-title":"Aust N Z J Ophthalmol"},{"issue":"3","key":"1474_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4103\/0974-9233.114805","volume":"20","author":"N Raoof","year":"2013","unstructured":"Raoof N, Quhill F. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease. Middle East Afr J Ophthalmol. 2013;20(3):256\u20138.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"5","key":"1474_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0002-9394(01)00896-0","volume":"131","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Honavar SG, et al. Classification and management of coats disease: the 2000 proctor lecture. Am J Ophthalmol. 2001;131(5):572\u201383.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1474_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1055\/s-0035-1545786","volume":"232","author":"V Strueven","year":"2015","unstructured":"Strueven V, Schalenbourg A, Wolfensberger TJ. Multiple arterial macroaneurysms in acquired Coats' disease in an adult - a case report. Klin Monatsbl Augenheilkd. 2015;232(4):583\u20134.","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"6","key":"1474_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4103\/ijo.IJO_841_19","volume":"67","author":"M Sen","year":"2019","unstructured":"Sen M, Shields CL, Honavar SG, Shields JA. Coats disease: an overview of classification, management and outcomes. Indian J Ophthalmol. 2019;67(6):763\u201371.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"1474_CR8","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ophtha.2004.12.038","volume":"112","author":"LM Smithen","year":"2005","unstructured":"Smithen LM, Brown GC, Brucker AJ, et al. Coats' disease diagnosed in adulthood. Ophthalmology. 2005;112(6):1072\u20138.","journal-title":"Ophthalmology"},{"issue":"3","key":"1474_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvp241","volume":"84","author":"S Apostolakis","year":"2009","unstructured":"Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009;84(3):353\u201360.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1474_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1167\/iovs.01-1202","volume":"44","author":"H Xu","year":"2003","unstructured":"Xu H, Forrester JV, Liversidge J, Crane IJ. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. Invest Ophthalmol Vis Sci. 2003;44(1):226\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1474_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/aos.13971","volume":"97","author":"J Zhang","year":"2019","unstructured":"Zhang J, Jiang C, Ruan L, Huang X. Associations of cytokine concentrations in aqueous humour with retinal vascular abnormalities and exudation in Coats' disease. Acta Ophthalmol. 2019;97(3):319\u201324.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"1474_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3341\/kjo.2008.22.3.190","volume":"22","author":"JH Jun","year":"2008","unstructured":"Jun JH, Kim YC, Kim KS. Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection. Korean J Ophthalmol. 2008;22(3):190\u20133.","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"1474_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10792-018-0827-0","volume":"39","author":"K Kumar","year":"2019","unstructured":"Kumar K, Raj P, Chandnani N, Agarwal A. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease. Int Ophthalmol. 2019;39(2):465\u201370.","journal-title":"Int Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01474-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T23:22:11Z","timestamp":1625008931000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01474-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01474-1","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for the publication of this case report, any additional related information and images was taken from the patient involved in the study. The informed consent obtained from the patient had been in writing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}